BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25512612)

  • 21. TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.
    Langlois T; da Costa Reis Monte-Mor B; Lenglet G; Droin N; Marty C; Le Couédic JP; Almire C; Auger N; Mercher T; Delhommeau F; Christensen J; Helin K; Debili N; Fuks F; Bernard OA; Solary E; Vainchenker W; Plo I
    Stem Cells; 2014 Aug; 32(8):2084-97. PubMed ID: 24723429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
    Guan Y; Tiwari AD; Phillips JG; Hasipek M; Grabowski DR; Pagliuca S; Gopal P; Kerr CM; Adema V; Radivoyevitch T; Parker Y; Lindner DJ; Meggendorfer M; Abazeed M; Sekeres MA; Mian OY; Haferlach T; Maciejewski JP; Jha BK
    Blood Cancer Discov; 2021 Mar; 2(2):146-161. PubMed ID: 33681816
    [No Abstract]   [Full Text] [Related]  

  • 23. DNA methyltransferase 1 functions through C/ebpa to maintain hematopoietic stem and progenitor cells in zebrafish.
    Liu X; Jia X; Yuan H; Ma K; Chen Y; Jin Y; Deng M; Pan W; Chen S; Chen Z; de The H; Zon LI; Zhou Y; Zhou J; Zhu J
    J Hematol Oncol; 2015 Feb; 8():15. PubMed ID: 25886310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
    Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
    BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tet2 restrains inflammatory gene expression in macrophages.
    Cull AH; Snetsinger B; Buckstein R; Wells RA; Rauh MJ
    Exp Hematol; 2017 Nov; 55():56-70.e13. PubMed ID: 28826859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.
    Gurnari C; Pagliuca S; Guan Y; Adema V; Hershberger CE; Ni Y; Awada H; Kongkiatkamon S; Zawit M; Coutinho DF; Zalcberg IR; Ahn JS; Kim HJ; Kim DDH; Minden MD; Jansen JH; Meggendorfer M; Haferlach C; Jha BK; Haferlach T; Maciejewski JP; Visconte V
    Blood Adv; 2022 Jan; 6(1):100-107. PubMed ID: 34768283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.
    Muto T; Sashida G; Oshima M; Wendt GR; Mochizuki-Kashio M; Nagata Y; Sanada M; Miyagi S; Saraya A; Kamio A; Nagae G; Nakaseko C; Yokote K; Shimoda K; Koseki H; Suzuki Y; Sugano S; Aburatani H; Ogawa S; Iwama A
    J Exp Med; 2013 Nov; 210(12):2627-39. PubMed ID: 24218139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome.
    Craven SE; French D; Ye W; de Sauvage F; Rosenthal A
    Blood; 2005 May; 105(9):3528-34. PubMed ID: 15650063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
    Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
    Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors.
    Qu X; Zhang S; Wang S; Wang Y; Li W; Huang Y; Zhao H; Wu X; An C; Guo X; Hale J; Li J; Hillyer CD; Mohandas N; Liu J; Yazdanbakhsh K; Vinchi F; Chen L; Kang Q; An X
    Blood; 2018 Nov; 132(22):2406-2417. PubMed ID: 30254129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TET2 as a gatekeeper for hematologic malignancies].
    Muto H; Sakata-Yanagimoto M; Chiba S
    Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish.
    De La Garza A; Cameron RC; Nik S; Payne SG; Bowman TV
    Exp Hematol; 2016 Sep; 44(9):826-837.e4. PubMed ID: 27260753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
    Boy M; Bisio V; Zhao LP; Guidez F; Schell B; Lereclus E; Henry G; Villemonteix J; Rodrigues-Lima F; Gagne K; Retiere C; Larcher L; Kim R; Clappier E; Sebert M; Mekinian A; Fain O; Caignard A; Espeli M; Balabanian K; Toubert A; Fenaux P; Ades L; Dulphy N
    Nat Commun; 2023 Feb; 14(1):588. PubMed ID: 36737440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Srsf2
    Xu JJ; Chalk AM; Wall M; Langdon WY; Smeets MF; Walkley CR
    Leukemia; 2022 Dec; 36(12):2883-2893. PubMed ID: 36271153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and Molecular Characterization of Transient tet1/2/3 Zebrafish Knockouts.
    Ross SE; Bogdanovic O
    Methods Mol Biol; 2021; 2272():281-318. PubMed ID: 34009621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.
    Meng C; Gu L; Li Y; Li R; Cao Y; Li Z; Allen EG; Zhu D; Jin P
    Hum Mol Genet; 2021 Oct; 30(21):1985-1995. PubMed ID: 34165552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis.
    Ransom DG; Bahary N; Niss K; Traver D; Burns C; Trede NS; Paffett-Lugassy N; Saganic WJ; Lim CA; Hersey C; Zhou Y; Barut BA; Lin S; Kingsley PD; Palis J; Orkin SH; Zon LI
    PLoS Biol; 2004 Aug; 2(8):E237. PubMed ID: 15314655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
    Coutinho DF; Monte-Mór BC; Vianna DT; Rouxinol ST; Batalha AB; Bueno AP; Boulhosa AM; Fernandez TS; Pombo-de-Oliveira MS; Gutiyama LM; Abdelhay E; Zalcberg IR
    Leuk Res; 2015 Oct; 39(10):1103-8. PubMed ID: 26277372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
    Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
    Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
    Jeong JJ; Gu X; Nie J; Sundaravel S; Liu H; Kuo WL; Bhagat TD; Pradhan K; Cao J; Nischal S; McGraw KL; Bhattacharyya S; Bishop MR; Artz A; Thirman MJ; Moliterno A; Ji P; Levine RL; Godley LA; Steidl U; Bieker JJ; List AF; Saunthararajah Y; He C; Verma A; Wickrema A
    Cancer Discov; 2019 Jun; 9(6):778-795. PubMed ID: 30944118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.